vimarsana.com

Page 37 - ஐரோப்பிய பல்கலைக்கழகம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EU ready to discuss COVID vaccine patent waiver, says von der Leyen

Article content BRUSSELS The European Union is willing to discuss a proposal, now backed by the United States, to waive intellectual property rights for COVID-19 vaccines, European Commission president Ursula von der Leyen said on Thursday. The head of the EU executive said the bloc’s vaccination effort was accelerating, with 30 Europeans being inoculated per second, while exporting more than 200 million vaccine doses to the rest of the world – contrasting with limited sharing of vaccines by the United States and Britain. We apologize, but this video has failed to load. Try refreshing your browser, or EU ready to discuss COVID vaccine patent waiver, says von der Leyen Back to video

EU considers COVID-19 vaccine patent waiver but Germany, drugmakers push back

Share on Twitter The European Union is willing to discuss a proposal to waive intellectual property rights for COVID-19 vaccines, European Commission President Ursula von der Leyen said on Thursday, as drugmakers fought their ground and their share prices slipped. US President Joe Biden voiced support on Wednesday for a waiver in a reversal of the US position, and his top trade negotiator, Katherine Tai, swiftly endorsed negotiations at the World Trade Organization. WHO chief Tedros Adhanom Ghebreyesus called Mr Biden s move a monumental moment in the fight against #COVID19 on Twitter, and said it reflected the wisdom and moral leadership of the United States .

EU ready to discuss COVID vaccine patent waiver, says von der Leyen

405 Brussels, May 6 The European Union is willing to discuss a proposal, now backed by the United States, to waive intellectual property rights for COVID-19 vaccines, European Commission president Ursula von der Leyen said on Thursday. The head of the EU executive said the bloc s vaccination effort was accelerating, with 30 Europeans inoculated per second, while exporting more than 200 million vaccine doses to the rest of the world. The EU is also ready to discuss any proposals that addresses the crisis in an effective and pragmatic manner, von der Leyen said in a speech to the European University Institute in Florence. That s why we are ready to discuss how the U.S. proposal for a waiver on intellectual property protections for COVID-19 vaccines could help achieve that objective.

Von der Leyen says EU ready to discuss Covid-19 vaccine patent waiver following US backing of proposal — RT World News

Follow RT on The European Commission president has said Brussels is prepared to look at a proposal to scrap intellectual property rights for Covid-19 vaccines in an effort to accelerate global vaccinations against the virus. Speaking on Thursday, European Commission President Ursula von der Leyen said the EU would be willing to look at proposals to waive Covid-19 vaccine patents after the US gave its backing to the plan on Wednesday.   “The EU is also ready to discuss any proposals that addresses the crisis in an effective and pragmatic manner,” von der Leyen said in a speech to the European University Institute in Florence.

EU says willing to discuss waiver of Covid-19 vaccine patents

EU says willing to discuss waiver of Covid-19 vaccine patents Issued on: 06/05/2021 - 17:12 A firefighter administers a dose of the Pfizer/BioNTech vaccine to a woman at the Covid-19 vaccination center Paris La Defense Arena in Nanterre, west of Paris on May 3, 2021. © Bertrand Guay, AFP (illustration) 7 min The European Union is willing to discuss a proposal, now backed by US President Joe Biden s administration, to waive intellectual property rights for Covid-19 vaccines, European Commission chief Ursula von der Leyen said on Thursday. Advertising Read more The head of the EU executive said the bloc s vaccination effort was accelerating, with 30 Europeans being inoculated per second, while exporting more than 200 million vaccine doses to the rest of the world - contrasting with limited sharing of vaccines by the United States and Britain.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.